Asthma Drugs Market Share, Analysis, and Growth by 2028
Asthma Drugs Market: Strategic Insights
Asthma Drugs Market
-
CAGR (2023 - 2031)5.00% -
Market Size 2023
US$ 26.72 Billion -
Market Size 2031
US$ 39.48 Billion
Market Dynamics
GROWTH DRIVERS
- The Rising Prevalence of Asthma Leads to an Increase in Demand for Asthma Drugs, Favors the Market Growth
FUTURE TRENDS
- Research Activities and Product Innovations
OPPORTUNITIES
- Commercialization of Biologics Creates Significant Opportunities in the Market
Key Players
- AstraZeneca
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Merck Co Inc
- Koninklijke Philips NV
- Sanofi
- Pfizer Inc
- Novartis AG
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Medications
- Quick Relief Medications and Long-Term Control Medications
Route of Administration
- Inhaled
- Prefilled Syringes/Vials
Distribution Channels
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies